Início
Explorar
nav.journalClub
Tendências
Mais
synapse
⌘+K
Idioma
Português
Português
Induced pluripotent stem cell (iPSC)-derived CAR-macrophages: new kids on the block | Synapse
March 3, 2026
Induced pluripotent stem cell (iPSC)-derived CAR-macrophages: new kids on the block
FZ
Fucai Zhu
Jiangxi Maternal and Child Health Hospital
ZC
Zhongfa Chen
Jiangxi Maternal and Child Health Hospital
YY
Yan Yu
Jiangxi Maternal and Child Health Hospital
See all
Key Points
iPSC-derived CAR-macrophages enhance immune response in targeted therapies, showing promise for treating various diseases.
Key evidence includes findings on the cellular interactions that improve functionality and survival rates in therapeutic contexts.
Assessment using iPSC technology to generate CAR-macrophages reveals significant advancements in immune targeting techniques.
Innovative approach may enable more effective treatments for immune-related conditions, but clinical applications need further exploration.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Zhu et al. (Sun,) studied this question.
synapsesocial.com/papers/69a7656ebadf0bb9e87d91a0
https://doi.org/https://doi.org/10.1016/j.exphem.2026.105384